Mass Tort Advertising Campaign

Talcum Powder / Ovarian Cancer Marketing & Claimant Acquisition

Johnson & Johnson's talcum powder products have been at the center of one of the most high-profile mass tort litigations in recent memory, with plaintiffs alleging that asbestos contamination in talc caused ovarian cancer and mesothelioma. For plaintiff firms currently in the MDL or evaluating entry, the advertising opportunity is real: a large, identifiable population of women used these products for a decade or more, and many have received diagnoses that align directly with the alleged mechanism of harm.

Intake is open, the litigation is active, and the claimant base is reachable through paid social. MTAA builds and manages Facebook and Instagram acquisition campaigns specifically designed to surface qualified talcum powder claimants — women with documented diagnoses and meaningful product-use histories — and move them efficiently through your intake funnel.

Talcum Powder / Ovarian Cancer at a glance

Substance / mechanism
Talc / Asbestos contamination
Manufacturer(s)
Johnson & Johnson
Associated injuries
Ovarian Cancer, Mesothelioma
Litigation status
Active MDL
Campaign intake
Open

The litigation landscape

The talcum powder litigation against Johnson & Johnson is consolidated in an MDL, reflecting the scale and complexity of claims alleging that asbestos-contaminated talc products caused ovarian cancer and mesothelioma. These are serious, life-altering diagnoses, and the volume of potential claimants who used J&J talc products over extended periods makes this one of the more substantive active mass torts in the plaintiff bar. The asbestos-contamination theory connects this litigation closely to the broader asbestos tort landscape — a comparison that experienced plaintiff attorneys will recognize as a signal of both the injury severity and the long latency periods involved.

Because mesothelioma and ovarian cancer can take years or decades to manifest after exposure, the claimant population spans a wide age range and geographic footprint, which is well-suited to Meta's targeting capabilities. Firms that move now on paid acquisition are positioning themselves ahead of any future consolidation or resolution activity that could tighten the intake window.

Who a campaign targets

How MTAA runs Talcum Powder / Ovarian Cancer campaigns

The creative strategy for talcum powder campaigns centers on recognition and trust. The J&J brand is one of the most widely recognized consumer names in the country, and many women used these products as part of a daily hygiene routine for years or decades — often without any awareness of the asbestos-contamination allegations. Effective ad creative meets that audience where they are: acknowledging the familiarity of the product, surfacing the connection to ovarian cancer or mesothelioma in plain language, and prompting women (or their family members) to find out whether a diagnosis may be linked. Facebook and Instagram are particularly well-suited here because the core claimant demographic — women who used these products regularly over many years — is highly reachable through Meta's interest and demographic targeting layers.

On the intake side, this tort benefits from a relatively clean qualification structure: use history and diagnosis are the two primary gates, which allows for efficient pre-screening before a lead reaches your intake team. MTAA builds campaign-to-intake flows that front-load those two questions, reducing unqualified volume and improving the economics of your acquisition spend. Given the injury severity and the active MDL posture, this is a tort where lead quality and intake speed both matter — and where a well-structured paid social program can deliver a consistent, scalable claimant pipeline.

Pricing

Mass Tort Ad Agency runs Talcum Powder / Ovarian Cancer campaigns on the same transparent model as every tort: actual Meta ad spend at cost plus a flat 15% management fee, a one-time $1,000 setup fee per tort, and $100 per signed retainer for CloudIntake qualification. No per-case markups, no lead resale, and the firm owns its ad account, pixel, creative, and claimant data.

Talcum Powder / Ovarian Cancer advertising — common questions

Is the talcum powder MDL still open to new claimants, and does that affect when we should start advertising?
Intake is currently open, which means paid acquisition campaigns can run now and feed your pipeline while the litigation is active. MDL posture can shift, and firms that build their claimant inventory earlier are generally better positioned if the intake window narrows. MTAA can scale spend up or down in response to litigation developments.
How does MTAA structure creative for a tort involving a brand as well-known as Johnson & Johnson?
The J&J brand recognition is actually a creative asset — it eliminates the need to explain what product is at issue, which shortens the path from ad impression to form submission. Creative focuses on the asbestos-contamination allegation, the specific diagnoses (ovarian cancer and mesothelioma), and the long-term daily-use pattern that characterizes the strongest claimants. We avoid sensationalism and keep messaging factual and direct, which performs well with this demographic on Meta.
What does the qualification screening look like, and how do you handle borderline cases like peritoneal cancer?
The primary qualification gates are duration of talcum powder use (with ten or more years being the strong-case threshold) and a confirmed diagnosis of ovarian cancer or mesothelioma. Our intake flows are built to capture both data points early. Peritoneal cancer cases without confirmed talc-use history are flagged as borderline and routed for attorney review rather than auto-qualified, keeping your intake team's time focused on the highest-value leads.
How does this tort compare to asbestos advertising in terms of audience reach and campaign structure?
The talcum powder tort shares meaningful structural similarities with asbestos litigation — serious diagnoses, long latency periods between exposure and illness, and a traceable product history — which means firms with asbestos intake experience will find the claimant-screening logic familiar. The key difference is that the exposure product here is a mass-market consumer good with near-universal brand recognition, which broadens the reachable audience on Meta considerably compared to occupational asbestos exposure campaigns.

Ready to run Talcum Powder / Ovarian Cancer campaigns?

We build, run, and qualify Talcum Powder / Ovarian Cancer claimant-acquisition campaigns end to end. Book a call and we'll walk you through the creative, audience, and intake plan.

Book a strategy call